Univariable logistic regression with CR initiation as dependent variable in a subsample referred for CR (N=82)
| Variable | CR initiation No (N=21) | CR initiation Yes (N=61) | OR (95% CI) | P value |
| Demographics | ||||
| Age | 63 (11.0) | 63 (19.0) | 0.98 (0.94 to 1.03) | 0.49 |
| Age ≤50 | 1 (1.2) | 12 (14.6) | 4.90 (0.60 to 40.21) | 0.14 |
| Age >50 | 20 (24.4) | 49 (59.8) | 0.20 (0.03 to 1.68) | 0.14 |
| Female sex (%) | 7 (33.3) | 11 (18.0) | 0.44 (0.14 to 1.35) | 0.14 |
| Higher education (%) | 16 (23.9) | 19 (31.1) | 1.92 (0.57 to 6.49) | 0.29 |
| Index event | ||||
| Acute coronary syndrome (%) | 6 (28.6) | 30 (49.2) | 2.42 (0.83 to 7.07) | 0.11 |
| Stable angina revascularisation (%) | 7 (33.3) | 23 (37.7) | 1.21 (0.43 to 3.44) | 0.72 |
| Atrial fibrillation (%) | 8 (38.1) | 7 (11.5) | 0.21 (0.07 to 0.69) | 0.01 |
| Admission type | ||||
| Acute admission index event | 6 (4.0) | 31 (20.8) | 2.58 (0.89 to 7.54) | 0.08 |
| Unplanned admission during study (%) | 1 (4.8) | 6 (9.8) | 2.18 (0.25 to 19.26) | 0.48 |
| Treatment index event | ||||
| PCI | 13 (61.9) | 52 (85.2) | 3.56 (1.49 to 11.00) | 0.03 |
| ECV | 8 (38.1) | 7 (11.5) | 0.21 (0.07 to 0.69) | 0.10 |
| Medication only | – | 2 (3.3) | – | – |
| Cardiac disease history | ||||
| Acute coronary syndrome | 3 (14.3) | 15 (24.6) | 1.96 (0.51 to 7.58) | 0.33 |
| PCI | 9 (42.9) | 22 (36.1) | 0.75 (0.27 to 2.07) | 0.58 |
| CABG | – | 4 (6.6) | – | – |
| Stroke | 2 (9.5) | 2 (3.3) | 0.33 (0.42 to 2.45) | 0.27 |
| Peripheral artery disease | 1 (4.8) | 2 (3.3) | 0.68 (0.06 to 7.88) | 0.76 |
| CVD risk factors | ||||
| Diabetes mellitus (%) | 4 (19.0) | 11 (18.0) | 0.94 (0.26 to 3.33) | 0.92 |
| Hypertension (%) | 8 (38.1) | 23 (37.7) | 0.98 (0.35 to 2.73) | 0.98 |
| Dyslipidaemia (%) | 5 (23.8) | 19 (31.1) | 1.45 (0.46 to 4.53) | 0.53 |
| Median BMI, kg/m2 (IQR) | 27.07 (1.16) | 27.02 (1.20) | 0.96 (0.78 to 1.18) | 0.69 |
| Psychological risk factors | ||||
| Median TSK kinesiophobia (IQR) | 29.00 (10.78) | 27.93 (7.00) | 0.92 (0.85 to 1.00) | 0.06 |
| Median GSES self-efficacy (IQR) | 32.67 (5.50) | 33.49 (7.00) | 1.18 (1.03 to 1.36) | 0.02 |
| Median HADS anxiety (IQR) | 7.00 (4.00) | 5.39 (4.99) | 0.89 (0.79 to 1.00) | 0.06 |
| Median HADS depression (IQR) | 5.00 (5.21) | 4.00 (5.70) | 0.93 (0.81 to 1.06) | 0.06 |
| Median IMSA biological complexity | 14 (2.63) | 15 (4.00) | 1.02 (0.88 to 1.18) | 0.84 |
| Median IMSA psychological complexity | 6.64 (4.0) | 5.42 (2.81) | 0.82 (0.66 to 1.00) | 0.06 |
| Median IMSA social complexity (IQR) | 7.89 (3.50) | 8.64 (3.00) | 1.02 (0.83 to 1.27) | 0.84 |
| Median CAQ cardiac anxiety | 26.45 (7.00) | 27.00 (11.00) | 0.97 (0.92 to 1.03) | 0.36 |
BMI, body mass index; CABG, coronary artery bypass grafting; CAQ, Cardiac Anxiety Questionnaire; CR, cardiac rehabilitation; CVD, cardiovascular disease; ECV, electrocardioversion; GSES, General Self-Efficacy Scale; HADS, Hospital Anxiety and Depression Scale; IMSA, InterMed Self-Assessment; PCI, percutaneous coronary intervention; TSK, Tampa Scale for Kinesiophobia.